Form D · Biotechnology
Eureka Genomics Corp
Hercules, CA · CIK 0001486566
Offering snapshot reported Mar 24, 2010 · SEC filing
- Reported sold
- $2.52M Offering amount: $2.52M
- Investors reported
- 36 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 10, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 24, 2010 | Initial | $2,518,977 | No comparison | 36 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $61.7K
- Form D file number
- 021-139914
The actual Total Offering Amount and Total Amount Sold is $2,518,976.14
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Grafton Corporation | None | |
| Titan Private Equity Group LLC | None |
Source: Form D, filed Mar 24, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Yuriy Fofanov | Director, Executive |
| Heather Koshinsky | Director, Executive |
| Jean Yves Lendormy | Executive |
| Didier Perez | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
750 Alfred Nobel Drive Suite 108
Hercules, CA, 94547
Hercules, CA, 94547